Zoll medical corporation evaluated the device and the device performed to specification.The device was put through extensive testing without duplicating the report.The device was recertified and returned to the customer.The review of clinical log files indicated that the second and eighth rapid shock analyses were classified by the algorithm as abnormal, but non shockable due to high normalized amplitude, qrs variability or low qrs variability and average peak to peak amplitude.The fifth rapid shock analysis was classified as non shockable due to high normalized amplitudes and the detection of some normal sinus rhythms.And finally, the sixteenth rapid shock was classified as non-shockable due to low waveform amplitude that was not high enough to be fine ventricular fibrillation.Based on our review of the data we have concluded that the analysis program worked within its limitations and that there was no indication of a malfunction with the device.Analysis of reports of this type has not identified an increase in trend.
|